Skip to main content

Table 1 Typical schedule for a patient enrolled in the CLEM protocol: summary of different stages

From: Study protocol on Alzheimer’s disease and related disorders: focus on clinical and imaging predictive markers in co-existing lesions

 

Baseline

Month 6

Month 12

Month 18

Month 24

Consent

    

 Inclusion/non inclusion criteria

    

 Medical history or event

 Clinical examination

 CDR

 

 

 DAD

 IADL

 MMSE

 

 

 Neuropsychological diagnosis testing

    

 ADAS-Cog/BREF

 

 

 NPI

 Medication

 Blood sampling

    

 Neurobiotec Biobank

    

 MRI

    

 SPECT-DaTscan®

    

 Amyloid PET

    

 LP (optional)